12.13.24 -- Where Are They Now? Teva Pharmaceuticals

Radiopharmaceuticals are on the brink of transforming cancer treatment and diagnostics. Learn more about how North Carolina has become the epicenter of this radioactive drug revolution.

Purified AAVs are prepared as a variety capsid species. To ensure gene therapy safety and efficacy, it is crucial to characterize and quantify those species.

Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.

The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.

Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.

Discover the advantages of a filling technology that provides faster readiness to good manufacturing practices (GMP) filling compared with traditional options.

How can Electronic Data Capture (EDC) tools streamline your data collection process and help you manage the increasing complexity and data?

Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, discusses how reducing the CGT supply chain complexity and introducing automation will help to benefit patients and the industry.